Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

Not yet recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Osimertinib
Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Not yet recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Cabozantinib
Study on the Best Treatment Sequence for Advanced Non-Small Cell Lung Cancer with EGFR Mutations Using Dacomitinib and Osimertinib

Not yet recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Dacomitinib
- Osimertinib
Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

Not yet recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Al8326
Study of Niraparib and Dostarlimab for Patients with Advanced Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma with Specific Genetic Mutations

Not yet recruiting

2 1 1 1
Investigated diseases:
- Pleural mesothelioma
- Non-small cell lung cancer
Investigated drugs:
- Niraparib
- Dostarlimab
Study on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer

Not yet recruiting

2 1 1
Investigated drugs:
- 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
+4
Study on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Not yet recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
- Docetaxel
+3
Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Not yet recruiting

3 1 1 1
Investigated drugs:
+7
Study of INCB099280 and Adagrasib for Adults with Advanced Solid Tumors with KRASG12C Mutation

Not yet recruiting

1 1 1
Investigated diseases:
Investigated drugs:
- Incb099280
- Adagrasib
Study of Disitamab Vedotin for Adults with Previously Treated HER2-Positive Solid Tumors, Including Lung, Head and Neck, Ovarian, and Endometrial Cancers

Not yet recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Disitamab Vedotin

Find clinical trials in your area

Matched clinical trials

We use cookies